DCF — TUCSON MEDICAL CENTER
Enterprise Value: $-430.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-430.6M
Enterprise Value
$-153.1M
PV of Cash Flows
$-277.5M
PV of Terminal Value
$-447.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $769.8M | $-17.6M | -2.0% | $-50.2M | $-45.7M |
| Year 2 | $792.9M | $-10.2M | -1.0% | $-43.8M | $-36.2M |
| Year 3 | $816.7M | $-2.4M | -0.0% | $-37.0M | $-27.8M |
| Year 4 | $841.2M | $1.8M | 0.0% | $-33.9M | $-23.1M |
| Year 5 | $866.4M | $4.0M | 0.0% | $-32.7M | $-20.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-430.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$747.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.02791905493111151
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5